Pharmaceutical company developing a synthetic version of psilocybin (found in magic mushrooms) for treatment-resistant depression. Its drug has completed key late-stage trials. Compass is the firm closest to filing an application for FDA approval of a psychedelic medicine.
In April 2026 Donald Trump signed an executive order boosting psychedelic medicines, including new research funding and priority vouchers to speed FDA review. The company said it aimed to submit its final data to the FDA in the third quarter of 2026.
bozone, n.: The substance surrounding stupid people that stops bright ideas from penetrating. The bozone layer, unfortunately, shows little sign of breaking down in the near future.